RAPT Therapeutics, Inc.RAPT Therapeutics, Inc.RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc.

No trades
See on Supercharts

Price target

2.670.000.00%
The 6 analysts offering 1 year price forecasts for RAPT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to RAPT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RAPT EPS for the last quarter is −0.47 USD despite the estimation of −0.58 USD. In the next quarter EPS is expected to reach −0.45 USD. Track more of RAPT Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter RAPT Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out RAPT Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RAPT price target is 2.67 USD with a max estimate of 4.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch RAPT Therapeutics, Inc. stock price chart and keep track of the current situation with RAPT news and stock market news.
We've gathered opinions of 10 analysts rating RAPT stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.